BofA analyst Tazeen Ahmad raised the firm’s price target on Ascendis Pharma (ASND) to $242 from $230 and keeps a Buy rating on the shares. The firm’s survey of 26 endocrinologists who treat HPT ...
Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 4300 in its research report dated 14, 2026.
12don MSN
Rodman & Renshaw Initiates Ascentage Pharma Group International (AAPG) with Buy Rating, $48 Target
We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. On January 14, Rodman & Renshaw initiated ...
Royalty Pharma Plc (NASDAQ:RPRX) is one of the best healthcare stocks under $50 to invest in. On January 30, Royalty Pharma ...
Mizuho analyst Graig Suvannavejh lowered the firm’s price target on Athira Pharma (ATHA) to $4 from $5 and keeps a Neutral rating on the shares following the 10-for-1 reverse stock split. The split ...
The average one-year price target for InnoCare Pharma (SEHK:9969) has been revised to HK$24.11 / share. This is an increase of 20.03% from the prior estimate of HK$20.09 dated November 16, 2025. The ...
The average one-year price target for Sumitomo Pharma Co. (OTCPK:DNPUF) has been revised to $13.38 / share. This is an increase of 39.32% from the prior estimate of $9.61 dated November 9, 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results